NCT03984747View on ClinicalTrials.gov

Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

September 14, 2018

Primary Completion Date

August 23, 2024

Study Completion Date

August 23, 2024

Conditions
Transplant RejectionAllograft RejectionComplications
Trial Locations (4)

10467

Children's Hospital at Montefiore, The Bronx

43221

The Ohio State University, Columbus

92123

Balboa United California Institute of Renal Research, San Diego

94070

Natera Inc., San Carlos

Sponsors

Lead Sponsor

Natera, Inc.
All Listed Sponsors
lead

Natera, Inc.

INDUSTRY

NCT03984747 - Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection | Biotech Hunter | Biotech Hunter